NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/11/2023
Back to search
Official data from USPTO
PHARMGKB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
07/11/2023
Trademark type
Word
Nice classes
42
Filing date
04/25/2001
Registration date
12/17/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2023
Last transaction
07/11/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/01/2000
First use in commerce
04/01/2000
Drawing code
1
Owner type
99
Owner location
BETHESDA, MD, US
Examiner
KEATING, MICHAEL
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
Representatives
Angela Y. Dai HHS OFFICE OF THE GENERAL COUNSEL
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Application service provider (ASP) featuring database software in the field of interplay between pharmacokinetics of drugs and genetic data including genes and polymorphisms
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/11/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/11/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/11/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
12/16/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/17/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/29/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/29/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/29/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/29/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
09/14/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/03/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/26/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/26/2009
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/04/2008
PLGL
ASSIGNED TO PARALEGAL
05/20/2008
E815
TEAS SECTION 8 & 15 RECEIVED
05/05/2008
CFIT
CASE FILE IN TICRS
03/28/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2002
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/03/2002
DOCK
ASSIGNED TO EXAMINER
10/03/2002
CNEA
EXAMINERS AMENDMENT MAILED
09/23/2002
CNRT
NON-FINAL ACTION MAILED
04/05/2002
DOCK
ASSIGNED TO EXAMINER
03/08/2002
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/15/2002
IUAF
USE AMENDMENT FILED
02/15/2002
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
01/15/2002
PUBO
PUBLISHED FOR OPPOSITION
10/23/2001
NPUB
NOTICE OF PUBLICATION
10/03/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/31/2001
DOCK
ASSIGNED TO EXAMINER
07/13/2001
PCGR
PETITION TO DIRECTOR GRANTED
06/27/2001
PCRC
PETITION TO DIRECTOR RECEIVED
04/25/2001
Continuous trademark protection
Get notified about every new filing that threatens PHARMGKB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.